ReviewThe Journal of clinical and aesthetic dermatology2017
A Review of the Global Guidelines on Surgical Margins for Nonmelanoma Skin Cancers.
Review in The Journal of clinical and aesthetic dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it.
- S2k guideline basal cell carcinoma of the skin (update 2023).Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2024Guideline
- Personalized digital pipeline for basal cell carcinoma delineation using hyperspectral imaging.Biomedical optics express · 2026Article
- Mohs Surgery vs. Wide Local Excision for Non-Melanoma Skin Cancer: Comparing Recurrence Rates, Economic Value, and Aesthetic Outcomes.Journal of cancer science and clinical therapeutics · 2026Article
- Postoperative Margin Management After Conventional Excision of Facial Basal and Squamous Cell Carcinomas: A Histotype-Specific Framework.Journal of skin cancer · 2026Article
- Correlation analysis between surgical margin status and recurrence of basal cell carcinoma in high-risk anatomical locations.Frontiers in surgery · 2026Article
- Guidelines for Clinicians and Pathologists on Performing Skin Biopsies and Reporting on Suspected Cutaneous Squamous Cell Carcinoma.Current oncology (Toronto, Ont.) · 2025Review
- Surgical Approaches to Pre-Auricular Cutaneous Squamous Cell Carcinomas Extending to the Temporal Bone.Head & neck · 2025Article
- Plaque-Like CD34-Positive Dermal Fibroma of the Toe: A Case Report and Review of the Literature.Cureus · 2025Article
- Risk factors for incomplete excision of cutaneous squamous cell carcinoma: A single-center study performed on 1082 excisions in Northern Italy.JPRAS open · 2025Article
- Aesthetic Reconstruction of Secondary Wounds after Extended Resection of Dermatofibrosarcoma Protuberans: A Retrospective Study in One Center.Journal of cosmetic dermatology · 2025Article
- Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Observational
- Global basal cell carcinoma in 55+ population: 1990- 2021 burden、risk-factor trends and 2050 forecast.Frontiers in oncology · 2025Article
- Is a 3 mm Surgical Margin Safe for Basal Cell Carcinoma in the Head and Neck that is Less than 2 cm, Considering Different Risk Factors?Archives of plastic surgery · 2024Article
- Article
- Unraveling the Enigma: A Report on a Rare Case of Cutaneous Horn, an Extraordinary Dermatological Occurrence.Cureus · 2023Article
- Measuring the quality of skin cancer management in primary care: A scoping review.The Australasian journal of dermatology · 2023Article
- Review
- Dermatoscopically narrowed surgical margins for head and neck basal cell carcinoma: A retrospective case-control study.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2022Article
- Supervised Autonomous Electrosurgery for Soft Tissue Resection.Proceedings. IEEE International Symposium on Bioinformatics and Bioengineering · 2021Article
- Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab.Annals of hematology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
28458773PMC5404779What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.